Nevertheless, the expression of M2a markers (that is, CD163 (Cd163), mannose receptor complex-1 (Mrc1) and arginase-1 (Arg1) was significantly upregulated in sST2 low-expressing tumours. This evidence concerns the gene CD163 and neoplasm.